David S Kinard

CIK 1752439 · View on SEC EDGAR ↗

Insider

First SEC filing: March 3, 2021 · Latest: March 3, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 23 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

23 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 11, 2019 ELAN P 7,977 22,569 Direct +54.67% Acquired (price as of 2026-08-20)
Sept. 24, 2018 ELAN P 2,500 $24.00 $60,000 2,500 Direct Acquired 0.9% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
July 1, 2026 ELAN Employee Stock Option (right to buy) Common Stock (25,620) $24.09 July 1, 2036 25,620 Acquired
March 1, 2022 ELAN Employee Stock Option(right to buy) Common Stock (23,026) $28.94 March 1, 2032 23,026 Acquired
Oct. 20, 2018 ELAN Non-Qualified Stock Option (Right-to-Buy) Elanco Animal Health Inc. Common Stock (21,086) $31.61 Oct. 20, 2028 21,086 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ELAN

President, Human Resources
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2019
2018

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.